ArisGlobal's New Generation Pharmacovigilance and Clinical Safety Solution Goes Live at Mitsubishi Tanabe Pharma Corporation

Major Upgrade Enables Organization to Submit Safety Reports to All Major Authorities Worldwide From a Single, Integrated Database and Web Application

<0> ArisGlobalLorra Gosselin+1.203.588.3000 </0>

ArisGlobal, a top provider of software solutions to the life science industry, announced today that Mitsubishi Tanabe Pharma Corporation has gone live with a new generation of ArisGlobal's comprehensive and pharmacovigilance and clinical safety solution.

The solution will help Mitsubishi Tanabe Pharma Corporation to meet its safety reporting needs at its headquarters in Japan, as well as its affiliates in the United States and Europe, with ease-of-use and increased business efficiency. The solution will equip Mitsubishi Tanabe Pharma Corporation with better capabilities to support the collection, assessment and distribution of both clinical and post-marketing adverse event data. It will also help the organization to unify and streamline the management of safety information across the world by consolidating multiple safety systems into one. Implementation of the new system was done by ArisGlobal's reseller and implementation partner in Japan, CTC Laboratory Systems Corporation, with the support of ArisGlobal.

ARISg and ARISj provide the functionality required to manage adverse event reporting requirements of different authorities around the world – from case entry to automatic generation of submission-ready adverse event reports. ARISg and ARISj have been successfully deployed by some of the largest pharmaceutical companies with large-scale, global operations, enabling them to implement efficient and effective Japanese and international pharmacovigilance and clinical safety programs.

"We are delighted to see Mitsubishi Tanabe Pharma Corporation go live with the ArisGlobal solution," said Deepak Abbhi, President & CEO of ArisGlobal. "The advanced functionalities and robust architecture of our solution allows our customers to meet the complex and rigorous safety reporting demands of regulatory agencies across the world including the PMDA here in Japan. The combination of ARISg and ARISj will provide Mitsubishi Tanabe Pharma Corporation with an efficient mechanism for sharing safety data while ensuring compliance across all regions"

ArisGlobal () is a leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and medical information. Hundreds of life science companies rely on ArisGlobal's advanced solutions for maintaining regulatory compliance, workflow automation, improving operational efficiency and easily sharing information around the globe.

Suggested Articles

The EMA and FDA will need traditional clinical trial hurdles removed if governments want the inoculations as quickly as possible.

In this week's EuroBiotech Report, Sitryx inks Lilly deal, Genfit downplays COVID-19 impact on NASH data and Gilead tests remdesivir in U.K.

Amgen and new partner Adaptive Biotechnologies are the latest pharma-biotech duo joining forces against the pandemic.